Sofinnova Investments’s ICU Medical ICUI Stock Holding History

Sofinnova Investments’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,000	Closed	-$776K	–	76
2024 Q4	$776K	Buy	+5,000	New	+$846K	0.06%	55

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Sofinnova Investments's ICUI Position: Q1 2025 in Review

Sofinnova Investments sold out of ICU Medical (ICUI) in Q1 2025, closing a stake of 5,000 shares — an estimated $776K sold.

Sofinnova Investments first reported a position in ICUI in Q4 2024 and held it in 1 quarter. The position peaked at $776K in Q4 2024. 281 funds tracked by Wall St. Rank hold ICUI as of Q1 2025.

Sofinnova Investments reported no remaining ICU Medical position as of Q1 2025 after selling out during the quarter.
Sofinnova Investments sold 5,000 ICU Medical shares in Q1 2025, an estimated $776K.
Sofinnova Investments first reported a position in ICU Medical in Q4 2024 and held it in 1 quarter.
Sofinnova Investments's ICU Medical position peaked at $776K in Q4 2024.
281 funds tracked by Wall St. Rank held ICU Medical as of Q1 2025.

Based on Sofinnova Investments's 13F filing for Q1 2025, filed 15 May 2025.